Webinar
On-Demand Webinar: Advancing Neuroinflammation Research with iPSC-Derived Microglia and Automated Assays for Drug Discovery
October 10, 2025
Are current neuroinflammation models constraining your research?
Watch our on-demand webinar to explore how Arctoris, EditCo and Brainxell are leveraging CRISPR-edited, iPSC-derived human microglia in automated, multiplexed assays to enhance disease modeling and drug discovery. This approach integrates human-relevant cellular models with mid-throughput automation and comprehensive neuroinflammatory readouts including phagocytosis, cytokine response, and inflammasome modulation.
Key Benefits:
- More Predictive: Human microglia models improve translational relevance
- More Efficient: Miniaturized, multiplexed assays optimize resources
- More Scalable: Automated workflows deliver reproducible, high-content data
Related poster:
Looking for more predictive neuroinflammation models?
Talk to an Expert